MedTrace Logo

Proteomics Study of Gastric Bypass Surgery to Treat Type 2 Diabetes Mellitus

NCT01870713 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2013-06-06

No results posted yet for this study

Summary

The purpose of this study is to reveal the key proteins involved in gastric bypassing surgery which may effect the decreased glucose in type 2 diabetes patietns, and evaluate standard remission rate as well as cost-benefit of gastric bypassing surgery for type 2 diabetes mellitus patients in China.

Conditions

Sponsors & Collaborators

  • No. 150 Central Hospital of the Chinese People Liberation Army

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-10-31
Completion
2013-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870713 on ClinicalTrials.gov